Read our expert Poonam Chindaliya explains five research frameworks to look at while analysing a sector and a company.
Read expert Kunal Rambhia’s take on if the formations and figures for Sun TV provide good opportunities.
The entire pharma sector has seen a sizeable time correction for a long time and is poised for a decent rally. Here is our expert, Kunal Rambhia’s technical observation on Lupin.
With the closing of Nord Stream 1 in Russia, Europe’s gas crisis has worsened and is slowly starting to take a permanent shape since Russia shut down the supply without intimating a date of reopening. Consequently, fears are looming large over the European economy and other countries.
As cautioned in the last article about the market, the week turned out to be bearish. Indices declined sharply. Need to be cautious in the short-term to mid-term as correction may get extended too. When such corrections emerge, there are 2 ways to approach the market.
The banks are now offering numerous services on their apps. Besides payments, savings, borrowing and shopping are other major uses of mobile apps.
There has been a ton of bullishness about the Price/Earnings-to-Growth (PEG) ratio being a great indicator to buy stocks. Motilal Oswal’s wealth creation studies did a great job explaining that buying stocks below a PEG of 1 and especially 0.5 lead to good wealth generation.
It’s been more than a month since the indices have consolidated, but the stock-specific move has continued. Metropolis lab has taken my attention as it’s available at the bargain buy level. Herein I share my technical view on the counter.
Markets have turned stock specifics, and our expert prefers it because of the favourable risk-reward. Read on to find out about one such counter: Aarti Drugs.
As discussed below, several macro factors indicate a strong demand pull. But lest you read too much optimism into these, remember that a huge part of this uptrend in macro data is a result of inflation.
